Skip to content

Clinical study of acupuncture treatment of post-stroke depression

Clinical study of acupuncture treatment of post-stroke depression

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071386
Enrollment
Unknown
Registered
2023-05-13
Start date
2023-05-20
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke depression

Interventions

Experimental group:''Xingnao Kaiqiao'' acupuncture + Antidepressant acupuncture treatment
Control group:''Xingnao Kaiqiao'' acupuncture + Escitalopram Tablets

Sponsors

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnostic criteria for post-stroke depression; 2. Experiencing a first stroke onset with a duration of 1 to 6 months; 3. Be aged 35 to 80 years (inclusive); 4. Hamilton Depression Scale (HAMD-17) score of 8 to 17 (inclusive); 5. Clear consciousness, stable vital signs, and cooperative physical examination.

Exclusion criteria

Exclusion criteria: 1. Those who have been treated with antidepressants within 2 weeks or are participating in other antidepressant clinical trials 2. Those with impaired consciousness or significant cognitive impairment of function (MMSE scale 180 µmol/L) 6. Pregnant and lactating women; 7. Intolerant or refusing to accept acupuncture/electroacupuncture.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale;

Secondary

MeasureTime frame
Clinical efficiency;Self-rating depression scale;

Countries

China

Contacts

Public ContactLi Menghan

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

limenghan01@126.com+86 137 0212 0982

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026